baber/WOPTO huggingface dataset:
Patent CA-2458144-A1 (CA)
Inventor: BODE JEFFREY
IPC: E21B43/08
Filed: 2004-02-17
Abstract: A connector for providing a pathway between a first screened tubing and a second screened tubing. In one embodiment, the connector includes an annular pipe coupled to the first screened tubing at a first end and coupled to the second screened tubing at a second end. The annular pipe defines a plurality of channels disposed therein. The channels are configured to provide the pathway between the first screened tubing and the second screened tubing.
Patent CA-2461390-A1 (CA)
Title: Beverage dispenser and automatic shut-off valve
Inventor: KREBS PHILIP M
IPC: B67D1/00
Filed: 2002-09-27
Abstract: A beverage mixing and dispensing valve, or a beverage dispenser including the valve, includes and automatic shut-off features. A user presses a cup or container against a lever (14) on a soft-drink dispenser. The lever closes a switch to activate the opening of a solenoid-operated valve (10). At the same time, a detection circuit is monitored to determine whether overflow of drink or foam has occurred. When drink or foam overflows and bridges a gap between two metal conductors (72) on the lever, resistance is lowered and electricity flows in the detection circuit. The valve then automatically shuts off the flow of beverage. Energy is saved in keeping the valve open using a pulse width modulation (PWM) technique for voltage to the solenoid, rather than using a steady-state voltage.
Patent CA-2461856-A1 (CA)
Inventor: LUBER JOSEPH
IPC: B30B11/08
Filed: 2002-09-26
Abstract: L'invention concerne des systèmes, des procédés et des appareils pour fabriquer des formes pharmaceutiques, ainsi que des formes pharmaceutiques produites au moyen de ces systèmes, procédés et appareils. La présente invention porte également sur de nouveaux modules de compression, de modelage par cycle thermique et de modelage par traitement thermique. Un ou plusieurs de ces modules peuvent être liés, de préférence au moyen d'un nouveau dispositif de transfert, dans un système global pour réaliser lesdites formes pharmaceutiques.
Patent CA-2463020-A1 (CA)
Title: Utilisation d'activateurs de gp130 dans la neuropathie diabetique
Inventor: VITTE PIERRE-ALAIN
IPC: A61K47/48
Filed: 2002-10-10
Abstract: L'invention concerne l'utilisation d'une substance de signalisation par l'intermédiaire de gp130 pour la fabrication d'un médicament destiné au traitement et/ou à la prévention de la neuropathie diabétique. De préférence, IL-6 est utilisé.
Patent CA-2463097-A1 (CA)
Title: Mechanism for implementing network discovery in a cable network
Inventor: BEEBE RANDOLPH R
IPC: H04N7/173
Filed: 2002-10-02
Abstract: The digital broadband delivery system (100) includes a headend controller (102) that receives network messages from the plurality of devices (ie. a sub-distribution network (160), node (106) and subscribers (108) ) and assigns transport stream identifiers (150 and 166) in the network . The plurality of devices ( (160), (106), and (108) ) are updated to respond to a first message by sending a network message to the controller (102), and the devices ( (160), (106), and (108) ) are adapted to monitor their received transport stream and respond to changes by sending a second network message to the controller (102). The controller (102) uses the received network messages to generate the transport stream map.
Patent CA-2465419-A1 (CA)
Inventor: RILEY TERENCE WILLIAM
IPC: A63B63/00
Filed: 2004-04-28
Abstract: The puck-deflector is a one-piece moulding in polyurethane, having a sloping apron for deflecting the puck up and into the net. The puck-deflector fits around the bottom pipe of the goalframe, and prevents incoming pucks from striking the bottom pipe, and rebounding back out over the goal-line.
Patent CA-2467356-A1 (CA)
Title: Selective norepinephrine serotonin reuptake inhibitors for treating fibromyalgia syndrome, chronic fatigue syndrome and pain
Inventor: KRANZLER JAY D
IPC: A61K31/165
Filed: 2002-11-05
Abstract: The present invention provides a method of treating, in a mammal, chronic fatigue syndrome (CFS), chronic fatigue syndrome (CFS) that is associated with depression, a combination of chronic fatigue syndrome (CFS) and fibromyalgia syndrome (FMS), fibromyalgia syndrome (FMS) associated with depression, pain and pain associated with depression. The method includes administering a therapeutically effective amount of a dual serotonin norepinepbrine reuptake inhibitor compound or a pharmaceutically acceptable salt thereof.
Patent CA-2473108-A1 (CA)
Inventor: CHOPP MICHAEL
IPC: A61K35/30
Filed: 2003-01-14
Abstract: L'invention concerne une substance thérapeutique permettant d'induire l'angiogenèse et la vasculogenèse. Cette substance thérapeutique contient des facteurs d'induction de l'angiogenèse et de la vasculogenèse isolés de cellules souches conjointement avec une thérapie cellulaire pharmaceutiquement acceptable. L'invention concerne également une méthode permettant d'amplifier la production des facteurs d'induction de l'angiogenèse et de la vasculogenèse sécrétés, cette méthode consistant à exposer des cellules souches à un composé et à co-cultiver ces cellules souches avec ce composé afin d'accroître la production de facteurs d'induction de l'angiogenèse et de la vasculogenèse. L'invention concerne en outre des facteurs d'induction de l'angiogenèse et de la vasculogenèse isolés et purifiés issus de cellules souches destinées à être utilisées dans une thérapie. L'invention concerne un procédé permettant d'obtenir les facteurs d'induction de l'angiogenèse et de la vasculogenèse tel qu'ils sont décrits ci-dessus, ce procédé consistant à isoler des cellules souches mésenchymateuses humaines du tissu et à les purifier avant leur différenciation, puis à les développer par culture ces cellules souches mésenchymateuses afin de produire un outil destiné à la thérapie neurologique et musculo-squelettique. L'invention concerne enfin des cellules souches mésenchymateuses isolées et développées par culture sous l'action d'un composé requis, lesquelles cellules permettent de différencier et de produire un phénotype cellulaire souhaité utile pour la réparation tissulaire.
Patent CA-2477082-A1 (CA)
Title: Preparation of n-methyl-3-hydroxy- 3-(2-thienyl)propylamine via novel thiophene derivatives containing carbamate groups as intermediates
Inventor: KRIMMER HANS-PETER
IPC: C07D333/22
Filed: 2003-01-30
Abstract: A novel route is described for the synthesis of N-methyl-3-hydroxy-3-(2-thienyl)propylamine IV, which can be used as a starting compound for the preparation of duloxetine. N-methyl-3-hydroxy-3-(2-thienyl)propylamine is synthesized via novel thiophene derivatives containing carbamate groups, I and IIa, as intermediates.
Patent CA-2477174-A1 (CA)
Title: Batchwise quilting of printed materials
Inventor: SCOTT DAVID BRIAN
IPC: D05B11/00
Filed: 2003-02-26
Abstract: A machine readable file is prepared for use in operating a print line that produces a layer or material (11) having a series of panels (15) printed thereon for quilting. The file includes information on the order in which panels are to be quilted, the amount of shrinkage that will occur to a panel during quilting and the amount of crop to be made between the adjacent panels following quilting. Such information is placed, preferably printed, onto the material at the print line. Such information is readable by a sensor (22) at a quilting station, which reads the information and controls a quilter (21) to quilt in accordance with the information. Shrinkage is also compensated for and appropriate crops are made between panels. A printer (14) is in part controlled by information read from the machine readable file, with other of the information from the machine readable file being placed in the records on the material.
Patent CA-2477376-A1 (CA)
Title: System and method for monitoring a packet network
Inventor: CHONG RAYMOND L
IPC: H04L69/40
Filed: 2003-03-19
Abstract: A method and system is provided for monitoring the quality of signal transmissions in a packet network by calculating Quality of Services (QoS) scores and corresponding Perceptual Speech Quality Measurement (PSQM) scores, and then monitoring a QoS score to predict a corresponding PSQM score. When the predicted PSQM score goes above a maximum value, an administrator of the packet network can determine if services may be needed to restore the quality of signal transmissions. The packet network may include a cable modem termination System (CMTS) [104]; a voice band Tester (VBT) [116] coupled to the CMTS [104]; a cable Modem Tester [108] coupled to the CMTS [104]; and a Voice over Internet Packet (VoIP) monitoring device [110] coupled to the CMTS  [104] and the voice band tester. The cable Modem Tester [108] is located at a location remote from the VBT.
Patent CA-2478159-A1 (CA)
Inventor: BARBERIO ALESSANDRO
IPC: A61F5/01
Filed: 2004-08-20
Abstract: A device for aerating a surgical cast, brace, splint or other orthopedic device is disclosed. The aerating device comprises a pair of flexible panels, each having opposed faces. One of said panels is adapted to permit air communication between its opposed faces. The panels are secured to one another in stacked relation, such that opposed faces of the panels define a pair of interior faces presenting toward one another and a pair of exterior faces presenting away from one another. Channels traverse the stack, between the panels, to permit, via passage between said panels, air communication between atmosphere and the interior face of said one of said pair of panels. The device can be wrapped around a limb, and a cast applied thereover. The channels permit evaporation of any moisture contained in the cast. A pressure-relieving device is also disclosed.
Patent CA-2478172-A1 (CA)
Title: Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
Inventor: STEINBERG MITCHELL IRVIN
IPC: A61P9/12
Filed: 2003-03-11
Abstract: he present invention relates to methods of treating pathological disorders susceptible to steroid hormone nuclear receptor modulation, particularly congestive heart failure, comprising administering to a patient in need thereof an effective amount of a compound of the formula: I or a pharmaceutically acceptable salt thereof. In addition, the present invention provides novel pharmaceutical compounds of Formula I, including the pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions which comprise as an active ingredient a compound of Formula I.
Patent CA-2481529-A1 (CA)
Title: Desulfurization system with enhanced fluid/solids contacting
Inventor: THOMPSON MAX W
IPC: C10G25/12
Filed: 2003-03-27
Abstract: A method and apparatus for removing sulfur from a hydrocarbon-containing flu id stream wherein desulfurization is enhanced by improving the contacting of th e hydrocarbon-containing fluid stream and sulfur-sorbing solid particulates in a fluidized bed reactor (12).
Patent CA-2486049-A1 (CA)
Title: Coated aluminum separator plates for fuel cells
Inventor: ALLIN JANE
IPC: B05D5/12
Filed: 2004-10-26
Abstract: A method of producing a separator plate for a low temperature fuel cell. In the method, a sheet article made of aluminum or aluminum alloy is coated with a layer of an electrically-conductive heat-activated polymerizable material, preferably dissolved or suspended in a volatile liquid. The article is preferably heated to a temperature below the full-cure temperature to drive off the volatile liquid to create a dried layer of polymerizable material. The surface is then coated with a catalyst to produce a catalyst-coated layer of polymerizable material. The article is then heated to the full-cure temperature to fully polymerize the polymerizable material and to attach the catalyst. The invention also relate to a separator plate having a structure indicated above.
Patent CA-2488865-A1 (CA)
Title: Context aware transmission management method
Inventor: GAL-OZ NIMROD
IPC: H04Q7/20
Filed: 2003-07-14
Abstract: The present invention comes to simplify and optimize the management of data transmission to set-top boxes for interactive and addressable applications.  The result is achieved by abstraction of the transmission process (40) for the application and addition of meta-data (20) to each message/stream using the invention, enabling automatic routing of the data (50) through the most suitable transmission path in real-time (70).
Patent CA-2489810-A1 (CA)
Title: Use of thio-oxindole derivatives in treatment of skin disorders
Inventor: FENSOME ANDREW
IPC: A61K31/4015
Filed: 2003-06-23
Abstract: The present invention provides methods of treating skin disorders includes delivering to a mammal a composition containing a compound of formula I, or tautomers thereof, in a regimen, wherein formula I is as shown and wherein R1-R5 and Q1 are defined as described herein. Specifically, methods for treating acne, hirsutism, and a composition for conditioning the skin are described.
Patent CA-2491150-A1 (CA)
Inventor: MSIKA PHILIPPE
IPC: A61Q19/08
Filed: 2003-06-25
Abstract: The invention concerns the use of isoflavones for preparing topical compositions for promoting slimming, and in particular for fighting against localized excess weight; the related cosmetic treatment method and a composition comprising additionally to isoflavones an extract of Sophora Japonica flowers.
Patent CA-2491237-A1 (CA)
Title: Assembly of bellows and co-acting part, pump and method for use thereof
Inventor: DE REGT JEROEN DANIEL
IPC: B05B11/00
Filed: 2003-07-03
Abstract: The present invention provides an assembly of bellows part and a part against which unrolling takes place (the unrolling part), comprising a bellows part with a flexible wall of a predetermined shape and thickness variation which co-operates with an unrolling part with a stiff outer wall along which the flexible wall is movable, wherein the unrolling part has a predetermined diameter variation and/or the flexible wall has a predetermined thickness variation so as to cause a desired development of force.
Patent CA-2492597-A1 (CA)
Title: Continuous chemical vapor deposition process and process furnace
Inventor: PRUETT JAMES GARY
IPC: C23C16/46
Filed: 2003-07-17
Abstract: An apparatus and process is provided for continuously depositing solid carbo n at atmospheric pressure onto the surfaces and in the porosity of a thin substrate material.
Patent CA-2494145-A1 (CA)
Inventor: EVANS RICHARD
IPC: B61L3/12
Filed: 2003-07-31
Abstract: A system and method for remotely controlling an increased number of subsystems having an onboard locomotive control unit (LCU) and two associated operator control units (OCUs) on a single wireless channel. A time slot is assigned to each subsystem for making two-way transmissions to control the locomotive. A  signal from an external timing source synchronizes each subsystem to minimize interference between transmissions from different subsystems. Time slots are assigned manually or automatically over a wireless network or by the LCU after monitoring the channel. The LCU automatically selects the direct or repeater transmission path depending upon whether or not it receives polling message responses from its associated OCUs. A GPS receiver in each subsystem receives the synchronization signal and provides geographic positioning data so the LCU  can determine when to execute predefined, position-based commands. The secondary OCU may be turned off and rejoined to the subsystem without ceasing operation.
Patent CA-2494674-A1 (CA)
Title: Inertia catch for a vehicle latch
Inventor: PEREVERZEV IGOR
IPC: E05B65/12
Filed: 2003-07-25
Abstract: A latch mechanism (20) for selectively latching a door (10) to an automotive vehicle. The latch mechanism includes a latch hook (22) movable between locked and unlocked positions relative to a striker bar (24) fixedly secured to the vehicle. A release lever (30) is operatively coupled between the latch hook (22) and the latch mechanism for selectively actuating the latch hook between the locked and unlocked positions. An inertia lever (50) is engagable with the release lever (30) to prevent movement of the latch hook (22) between the unlocked and locked positions. The inertia lever (50) is movably coupled to the latch mechanism for movement in and out of engagement with the release lever (30) in response to a threshold acceleration of the vehicle. A slot (42) is formed in the release lever (30) presenting sides (44, 46) engagable with the inertia lever (50) to automatically rock the inertia lever in response to movement of the release lever (30) to prevent seizing of the inertia lever within the latch mechanism due to lack of use.
Patent CA-2498348-A1 (CA)
Title: Dryer fabric with air channels on the backside
Inventor: BARBERY RICK
IPC: D21F1/00
Filed: 2003-10-24
Abstract: A papermaker~s fabric (10), usable with a dryer section on a paper machine, has a first layer (14) and a second layer (16) of cross-machine-direction (CD) yarns (21-32). Interwoven with the CD yarns in a duplex weave is a system of MD yarns (41-52). The MD yarns are provided in groups of at least two adjacent MD yarns. Each group has one first MD yarn (41, 44, 47, 50) and one or more second MD yarn. The first MD yarn interweaves between the first and second layers of CD yarns, each time binding with only one CD yarn. Each second MD  yarn also interweaves between first and second layers of CD yarns, each time binding with only one CD yarn in the first layer, but floating over at least two CD yarns in the second layer. The first MD yarn is between the one or more second MD yarns in its group and those of an adjacent group, and defines a continuous air channel (60) on the surface of the fabric.
Patent CA-2499786-A1 (CA)
Inventor: GINGRAS DAVID
IPC: B62D55/14
Filed: 2005-03-02
Abstract: There is provided a wheel assembly and associated method of mounting wheels about a hub, by providing a hub comprising a shoulder having a clearing space allowing a wheel introduced by one side of the hub to be pivoted to an opposite side thereof.
Patent CA-2499885-A1 (CA)
Title: Novel polyphosphate:amp phosphotransferase
Inventor: NOGUCHI TOSHITADA
IPC: C12N15/54
Filed: 2003-05-28
Abstract: This invention relates to a novel polyphosphate:AMP  phosphotransferase (PAP), a gene coding this PAP, and their use. The PAP has the following properties:   (A) action: catalyzing of the following two reactions:  NMP + PolyP(n) .fwdarw. NDP + PolyP(n-1) dNMP + PolyP(n) .fwdarw. dNDP + PolyP(n-1) (wherein NMP represents nucleoside monophosphate, NDP  represents nucleoside diphosphate, dNMP represents deoxynucleoside monophosphate, dNDP represents deoxynucleoside diphosphate, n represents degree of polymerization of the polyphosphate which is an integer of up to 100);   (B) substrate specificity: specific to AMP, GMP, IMP, dAMP, and dGMP, also acting with CMP, UMP, dCMP, and TMP;  (C) molecular weight: about 55 to 56 Kd (kilodalton);  and (D) specific activity: at least 70 units per 1 mg of enzyme protein,
Patent CA-2500335-A1 (CA)
Inventor: DIMATTEO KRISTIAN
IPC: A61M39/02
Filed: 2003-10-06
Abstract: A medical device (10) comprising suture wings (41) that can be detached or attached at various receiving positions about the housing (11) and entry site (12) of the medical device, allows subcutaneous suturing of the device in a manner and at locations as determined by the physician. The suture wings (41) can each comprise one or more suture locations (14), and can also include a filling material (110) to inhibit tissue ingrowth. If desired, all suture wings can be removed from the medical device. The versatility of the device allows one type of device to be used to accommodate the needs of the different techniques and different methods used by many different physicians.
Patent CA-2500798-A1 (CA)
Inventor: BEDARIDA LORENZO
IPC: G11C16/16
Filed: 2003-09-04
Abstract: L'invention concerne une mémoire flash comprenant une nouvelle architecture d'effacement de page utilisant un mécanisme de décodage local au lieu du mécanisme de décodage global connu dans l'état de la technique. Cette nouvelle architecture permet de sauvegarder plus de zone de matrice pour les cellules mémoire et empêche un effacement indésirable sans affecter le temps de lecture. Avec le mécanisme de décodage local, la mémoire est découpée en secteurs (222, 804), chaque secteur comprenant une pluralité de décodeurs locaux (202) et un circuit local. Ledit circuit local comprend des commutateurs (302, 304, 306) commandés par les décodeurs globaux (802), ces commutateurs étant commutés uniquement pendant une opération d'effacement et non pendant une opération de lecture. Le temps de lecture n'est pas affecté. Chaque décodeur local est couplé à une rangée (212) de la matrice mémoire. Chaque décodeur local comprend un transistor PMOS (204) permettant de faire passer des tensions positives et deux transistors NMOS (206, 208) permettant de faire passer des tensions négatives de sorte qu'il est possible d'effacer une page et les rangées non sélectionnées peuvent être protégées contre un effacement indésirable sans circuit additionnel et complexe. Le décodeur global (802, 900, 1000) est situé à l'extérieur des secteurs (804) et fournit des signaux globaux (GLOB_SRC_SEL, WS, WSN, SG) à tous les secteurs via le circuit local, ce qui permet de sauvegarder la zone de matrice.
Patent CA-2501875-A1 (CA)
Inventor: ENDOH HIDEKI
IPC: C12N1/19
Filed: 2003-10-09
Abstract: A novel polypeptide which is useful in screening an insulin resistance improving agent and a saccharometabolism improving agent; a polynucleotide encoding the above polypeptide; an expression vector containing the above polynucleotide; and cells transformed by the above expression vector. The above-described polypeptide is a protein which is expressed in skeletal muscle and the overexpression of which inhibits the uptake of saccharides into cells.  A method of screening an insulin resistance improving agent and a saccharometabolism improving agent by using the above polypeptide; and a process for producing a medicinal composition for improving insulin resistance and/or improving saccharometabolism which comprises a substance obtained by the above screening method as the active ingredient.
Patent CA-2504008-A1 (CA)
Title: Novel imidazopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
Inventor: CAIGNARD DANIEL-HENRI
IPC: A61P3/10
Filed: 2003-11-04
Abstract: The invention concerns compounds of formula (I), wherein R<1> represents a hydrogen, halogen atom, an alkyl, polyhalogenoalkyl, cyano, nitro, hydroxycarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, or dialkylaminocarbonyl group; R<2> represents a hydrogen atom, an alkyl, aryl group optionally substituted, heteroaryl optionally substituted or a R<20>-C(X) group, R<20> representing an alkyl, alkoxy, amino, alkylamino, dialkylamino, aryl optionally substituted or heteroaryl group; X represents an oxygen atom, a sulphur atom, or a NR<21> group, wherein R<21> represents a hydrogen atom or an alkyl group; R<3> represents a hydrogen atom or an alkyl group; n represents an integer between 1 and 6 inclusively, R<1> has the following meanings (A); their enantiomers, diastereoisomers, as well as their addition salt to a pharmaceutically acceptable acid or base. The invention is useful for preparing medicines.